Katarina Luptakova
Net worth: 22 753 $ as of 30/06/2026
Net worth: 22 753 $ as of 30/06/2026
Katarina Luptakova worked at Tesaro, Inc. from 2017 to 2020, serving as Senior Medical Director from 2018 to 2020.
From 2020 to 2021, worked at Constellation Pharmaceuticals, Inc. as Vice President-Clinical Development.
From 2022 to 2023, worked at Xilio Therapeutics, Inc. as Senior Vice President-Medical.
Education includes a doctorate from the University of Commenius.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/01/2026 | 2,375 ( 0.04% ) | 22 753 $ | 30/06/2026 |
| Companies | Position | End |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2021 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 01/04/2020 |
| XILIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
University of Commenius
University of Commenius Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions